MY145788A - Antitumoral dihydropyran-2-one compounds - Google Patents

Antitumoral dihydropyran-2-one compounds

Info

Publication number
MY145788A
MY145788A MYPI20085040A MYPI20085040A MY145788A MY 145788 A MY145788 A MY 145788A MY PI20085040 A MYPI20085040 A MY PI20085040A MY PI20085040 A MYPI20085040 A MY PI20085040A MY 145788 A MY145788 A MY 145788A
Authority
MY
Malaysia
Prior art keywords
compounds
antitumoral
dihydropyran
species
antitumoral dihydropyran
Prior art date
Application number
MYPI20085040A
Other languages
English (en)
Inventor
Martin Lopez Ma Jesus
Fernandez Rodriguez Rogelio
Coello Molinero Laura
Reyes Benitez Jose Fernando
Rodriguez Vicente Alberto
Garranzo Garcia-Ibarrola Maria
Murcia Perez Carmen
Francesch Solloso Andres
Sanchez Sancho Francisco
Cuevas Marchante Maria Del Carmen
Original Assignee
Pharma Mar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Mar Sa filed Critical Pharma Mar Sa
Publication of MY145788A publication Critical patent/MY145788A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/38—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms one oxygen atom in position 2 or 4, e.g. pyrones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/32—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
MYPI20085040A 2006-06-16 2007-06-15 Antitumoral dihydropyran-2-one compounds MY145788A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06380173 2006-06-16

Publications (1)

Publication Number Publication Date
MY145788A true MY145788A (en) 2012-04-30

Family

ID=38508885

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20085040A MY145788A (en) 2006-06-16 2007-06-15 Antitumoral dihydropyran-2-one compounds

Country Status (29)

Country Link
US (2) US8324406B2 (enExample)
EP (3) EP2404913A3 (enExample)
JP (2) JP5117491B2 (enExample)
KR (1) KR101474031B1 (enExample)
CN (2) CN102336730A (enExample)
AR (1) AR061506A1 (enExample)
AT (1) ATE522514T1 (enExample)
AU (1) AU2007259257B8 (enExample)
BR (2) BRPI0713031B8 (enExample)
CA (1) CA2654334C (enExample)
CY (1) CY1112103T1 (enExample)
DK (1) DK2032551T3 (enExample)
ES (1) ES2371942T3 (enExample)
HR (1) HRP20110845T1 (enExample)
IL (1) IL195676A (enExample)
MX (1) MX2008015754A (enExample)
MY (1) MY145788A (enExample)
NO (2) NO341508B1 (enExample)
NZ (1) NZ573706A (enExample)
PL (1) PL2032551T3 (enExample)
PT (1) PT2032551E (enExample)
RS (1) RS52034B (enExample)
RU (2) RU2444519C2 (enExample)
SG (1) SG174830A1 (enExample)
SI (1) SI2032551T1 (enExample)
TW (2) TWI373469B (enExample)
UA (1) UA97369C2 (enExample)
WO (1) WO2007144423A1 (enExample)
ZA (1) ZA200810315B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2597091B1 (en) 2007-12-20 2016-04-20 Pharma Mar, S.A. Antitumoral Compounds
MX2010008922A (es) 2008-02-20 2010-09-07 Actelion Pharmaceuticals Ltd Compuestos antibioticos azatriciclicos.
ES2398939T3 (es) 2008-02-22 2013-03-22 Actelion Pharmaceuticals Ltd. Derivados de oxazolidinona
MY158520A (en) 2008-10-07 2016-10-14 Actelion Pharmaceuticals Ltd Tricyclic oxazolidinone antibiotic compounds
BRPI0920870A2 (pt) 2008-10-10 2018-06-26 Actelion Pharmaceuticals Ltd antibióticos de oxazolidinila.
WO2010149688A2 (en) 2009-06-24 2010-12-29 Pharma Mar, S.A. Antitumoral compounds
GB201309807D0 (en) * 2013-05-31 2013-07-17 Pharma Mar Sau Antibody drug conjugates
CN108467378A (zh) * 2017-02-23 2018-08-31 复旦大学 一种二氢吡喃酮类化合物及其制备方法和用途
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام
CN110790737B (zh) * 2019-11-07 2022-07-22 河南中烟工业有限责任公司 一种2,3-二氢-3,5-二羟基-6-乙基-4h-吡喃-4-酮的制备方法
TW202330486A (zh) 2021-10-22 2023-08-01 西班牙商瑪製藥股份有限公司 抗腫瘤化合物
CN117510448A (zh) * 2023-11-13 2024-02-06 贵州中医药大学 一种二氢吡喃酮衍生物及其制备方法与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA938019B (en) * 1992-11-13 1995-04-28 Upjohn Co Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating HIV and other retroviruses
PT1142887E (pt) * 1993-11-19 2004-08-31 Parke Davis & Co Derivados de 5,6-di-hidropirona como inibidores de protease e agentes antivirais
US7446196B2 (en) * 2004-06-03 2008-11-04 Kosan Biosciences, Incorporated Leptomycin compounds

Also Published As

Publication number Publication date
US20090186938A1 (en) 2009-07-23
NO20111248L (no) 2008-12-16
HK1130052A1 (en) 2009-12-18
EP2404912A3 (en) 2012-07-25
NZ573706A (en) 2011-09-30
CA2654334A1 (en) 2007-12-21
WO2007144423A1 (en) 2007-12-21
AU2007259257A8 (en) 2012-04-05
JP5117491B2 (ja) 2013-01-16
KR101474031B1 (ko) 2014-12-17
AR061506A1 (es) 2008-09-03
JP2012021023A (ja) 2012-02-02
HRP20110845T1 (hr) 2011-12-31
SG174830A1 (en) 2011-10-28
BRPI0713031B1 (pt) 2020-10-06
UA97369C2 (ru) 2012-02-10
EP2404913A2 (en) 2012-01-11
KR20090024261A (ko) 2009-03-06
NO20090054L (no) 2009-01-06
ATE522514T1 (de) 2011-09-15
CN101679340B (zh) 2013-06-05
MX2008015754A (es) 2009-01-12
RU2011133128A (ru) 2013-02-10
IL195676A0 (en) 2009-09-01
TW200811128A (en) 2008-03-01
US8501968B2 (en) 2013-08-06
PT2032551E (pt) 2011-12-06
CN102336730A (zh) 2012-02-01
DK2032551T3 (da) 2012-01-02
US20120190870A1 (en) 2012-07-26
TWI373469B (en) 2012-10-01
RU2009101150A (ru) 2010-07-27
ES2371942T3 (es) 2012-01-11
US20100048690A2 (en) 2010-02-25
EP2032551B1 (en) 2011-08-31
AU2007259257A1 (en) 2007-12-21
SI2032551T1 (sl) 2012-01-31
BRPI0722429A2 (pt) 2013-11-26
US8324406B2 (en) 2012-12-04
AU2007259257B8 (en) 2012-04-05
BRPI0713031A2 (pt) 2013-03-12
CA2654334C (en) 2014-06-10
PL2032551T3 (pl) 2012-01-31
EP2404912A2 (en) 2012-01-11
EP2404913A3 (en) 2012-06-06
EP2032551A1 (en) 2009-03-11
ZA200810315B (en) 2010-02-24
BRPI0713031B8 (pt) 2021-05-25
TW201213316A (en) 2012-04-01
EP2032551B9 (en) 2012-02-29
RS52034B (sr) 2012-04-30
IL195676A (en) 2012-06-28
CN101679340A (zh) 2010-03-24
CY1112103T1 (el) 2015-11-04
RU2444519C2 (ru) 2012-03-10
NO341508B1 (no) 2017-11-27
JP2009539943A (ja) 2009-11-19
AU2007259257B2 (en) 2011-12-08

Similar Documents

Publication Publication Date Title
MY145788A (en) Antitumoral dihydropyran-2-one compounds
UA94833C2 (en) Substituted bicyclolactams
WO2008083248A3 (en) Cyclopamine analogs
WO2006092213A8 (de) Pyrazolylcarboxanilide
WO2009156462A3 (en) Organic compounds
WO2007120980A3 (en) 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases
WO2007028135A3 (en) Imidazopyridine compounds
MX2010006738A (es) Inhibidores de proteasa del virus de la hepatitis c (hcv) y usos de los mismos.
MX2010006736A (es) Inhibidores de proteasa del virus de la hepatitis c (hcv) y usos de los mismos.
TN2010000101A1 (en) Fungicidal 2-alkylthio-2-quinolinyloxy -acetamide derivatives
AU2008303600A8 (en) 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives
GB0521508D0 (en) Organic compounds
MX2007014172A (es) Procedimiento para la produccion de 4-bifenililacetidina-2-onas fenolicos.
WO2008153154A1 (ja) 環状化合物、フォトレジスト基材及びフォトレジスト組成物
TW200617019A (en) A process for the preparation of 7α-alkylated 19-norsteroids
MY142105A (en) Leukotriene biosynthesis inhibitors
MX2007008723A (es) Polipeptidos de yersinia spp y metodos de uso.
HRP20080057T3 (en) 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof
MX2009006337A (es) Analogos de epotilona modificados en las posiciones c12-c13, como farmacos contra el cancer.
TW200613308A (en) Cyclobutanetetracarboxylate compound and preparation method thereof
TW200738649A (en) Calcilytic compounds
TW200732410A (en) Sprayable acoustic compositions
TW200745039A (en) Isotopically substituted pantoprazole
TW200806304A (en) Maitake mushroom extract and composition containing the same for enhance production of sebum
TW200728310A (en) Process for the preparation of ferri-succinylcasein